Correlation between the in vivo efficacy of GPIIB/IIIA receptor antagonists and ex vivo platelet inhibition:: Role of calcium.

被引：0
|
作者：
Huang, J [1 ]
Rebello, SS [1 ]
Faul, JD [1 ]
Lucchesi, BR [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
来源：
FASEB JOURNAL | 1998年 / 12卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1113
引用
收藏
页码：A191 / A191
页数：1
相关论文
共 40 条
  • [21] Comparative efficacy of different platelet GPIIb/IIIa receptor antagonists on tissue factor (TF)-Induced platelet-mediated clot strength using thromboelastography (TEG).
    Mousa, SA
    Forsythe, MS
    FASEB JOURNAL, 1999, 13 (05): : A837 - A837
  • [22] Synergy between low molecular weight heparin, Tinzaparin and platelet GPIIb/IIIa antagonists, ReoPro and Roxifiban in improving antiplatelet and anticoagulant efficacy
    Mousa, SA
    Forsythe, M
    Walenga, J
    Fareed, J
    THROMBOSIS AND HAEMOSTASIS, 1999, : 857 - 858
  • [23] SE 214857: A novel nm peptide orally active potent and selective platelet GPIIb/IIIa receptor antagonist: In vitro and in vivo pharmacology
    Feuerstein, G
    Wong, A
    Nichols, A
    Samanen, J
    Stadel, JM
    VaskoMoser, J
    Koster, P
    Valocik, R
    CIRCULATION, 1996, 94 (08) : 3007 - 3007
  • [24] Is there a correlation between the effects of calcium channel antagonists on ethanol withdrawal hyperexcitability in vivo and in vitro?
    Bailey, CP
    Molleman, A
    Little, HJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 : P65 - P65
  • [25] Comparative efficacy of roxifiban versus other platelet GPIIb/IIIa receptor antagonists on tissue factor (TF)-induced platelet-mediated clot strength using thromboelastography (TEG)
    Mousa, SA
    Forsythe, M
    THROMBOSIS AND HAEMOSTASIS, 1999, : 830 - 830
  • [26] Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects
    Smith, A
    McPherson, J
    Taylor, M
    Mason, A
    Carney, S
    Gillies, A
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (12) : 783 - 788
  • [27] Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects
    A Smith
    J McPherson
    M Taylor
    A Mason
    S Carney
    A Gillies
    Journal of Human Hypertension, 1997, 11 : 783 - 788
  • [28] Antithrombotic map of the N-terminal domain of the GPIIIa subunit of the human platelet fibrinogen receptor (GPIIb-IIIa) determined in vivo by monoclonal, immunochemical inhibition of acute arterial thrombosis
    Escudero, C
    Alvarez, MV
    deHaro, J
    Alvarez, L
    Millan, I
    CastilloOlivares, JL
    GonzalezRodriguez, J
    PLATELETS, 1997, 8 (05) : 349 - 354
  • [29] Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor The APTITUDE Study
    O'Connor, Stephen A.
    Amour, Julien
    Mercadier, Anne
    Martin, Rejane
    Kerneis, Mathieu
    Abtan, Jeremie
    Brugier, Delphine
    Silvain, Johanne
    Barthelemy, Olivier
    Leprince, Pascal
    Montalescot, Gilles
    Collet, Jean-Philippe
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (11)
  • [30] MYOCARDIAL SALVAGE EFFICACY OF A THROMBOXANE RECEPTOR ANTAGONIST, SQ-30,741, IN RELATION TO INHIBITION EX-VIVO OF PLATELET-FUNCTION IN THE FERRET
    GOMOLL, AW
    OGLETREE, ML
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1993, 46 (03) : 233 - 242
1234